Isobavachalcone: An overview

Chinese Journal of Integrative Medicine

Volumn 18, Issue 7, 2012, Pages 543-547

  Kuete, Victor ^a   Sandjo, Louis P ^b  

^a UNIVERSITY OF DSCHANG   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Biosynthesis; Isobavachalcone; Pharmacology; Synthesis

Indexed keywords

CHALCONE DERIVATIVE; FLAVONOID; ISOBAVACHALCONE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CLUSIACEAE; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; FABACEAE; MORACEAE; PRIORITY JOURNAL; PSORALEA; PSORALEA CORYLIFOLIA; REVIEW; SCHISANDRACEAE; SYNTHESIS;

ANIMALS; BIOSYNTHETIC PATHWAYS; CELL DEATH; CHALCONES; HUMANS;

EID: 84867297651     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1142-7     Document Type: Review

References (49)

1. Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007;42:125-137.
2. Bhalla VX, Nayak UR, Dev S. Some new fiavonoids from Psoralea Corylifolia. Tetrahedron Lett 1968; 20:2401-2406.
3. Tsai WJ, Hsin WC, Chen CC. Antiplatelet flavonoids from seeds of Psoralea corylifolia. J Nat Prod 1996;59:671-672.
4. Pistelli L, Spera K, Flamini G, Mele S, Morelli I. Isoflavonoids and chalcones from Anthyllis hermanniae. Phytochemistry 1996;42:1455-1458.
5. Yenesew A, Midiwo JO, Guchu SM, Heydenreich M, Peter MG. Three isoflav-3-enes and a 2-arylbenzofuran from the root bark of Erythrina burttii. Phytochem 2002;59:337-341.
6. Innok P, Rukachaisirikul T, Suksamrarn A. Flavanoids and pterocarpans from the bark of Erythrina fusca. Chem Pharm Bull 2009;57:993-996.
7. Qiao CF, Han QB, Song JZ, Mo SF, Kong LD, Kung HF, et al. Chemical fingerprint and quantitative analysis of Fructus psoraleae by high-performance liquid chromatography. J Sep Sci 2007;30:813-818.
8. Asada Y, Li W, Yoshikawa T. Isoprenylated flavonoids from hairy root cultures of Glycyrrhiza glabra. Phytochem 1998;47:389-392.
9. Kobayashi M, Noguchi H, Sankawa U. Formation of chalcone and isoflavone by callus culture of Glycyrrhiza uralensis with different production patterns. chem Pharm Bull 1985;33:3811-3816.
10. Iinuma M, Ohyama M, Tanaka T. Flavonoids in roots of Sophora prostrata. Phytochemistry 1995;38:539-543.
11. Chung MI, Lai MH, Yen MH, Wu RR, Lin CN. Phenolics from Hypericum geminiflorum. Phytochemistry 1997;44:943-947.
12. ElSohly HN, Joshi AS, Nimrod AC, Walker LA, Clark AM. Antifungal chalcones from Maclura tinctoria. Planta Med 2001;67:87-89.
13. Mbaveng TA, Ngameni B, Kuete V, Simo IK, Ambassa P, Roy R, et al. Antimicrobial activity of the crude extracts and five flavonoids from the twigs of Dorstenia barteri (Moraceae). J Ethnopharmacol 2008;116:483-489.
14. Tsopmo A, Tene M, Kamnaing P, Ngnokam D, Ayafor JF, Sterner O. Geranylated flavonoids from Dostenia poinsettifolia. Phytochemistry 1998;48:345-348.
15. Ngameni B, Kuete V, Simo IK, Mbaveng AT, Awoussong PK, Patnam R, et al. Antibacterial and antifungal activities of the crude extract and compounds from Dorstenia turbinata (Moraceae). S Afr J Bot 2009;75:256-261.
16. Lee D, Krishna PL, Bhat H, Fong HS, Farnsworth RN, Pezzuto JM, et al. Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod 2001;64:1286-1293.
17. Metuno R, Ngandeu F, Tchinda AT, Ngameni B, Kapche GDWF, Djemgou PC, et al. Chemical constituents of Treculia acuminata and Treculia africana (Moraceae). Biochem Syst Ecol 2008;36:148-152.
18. Abegaz BM, Ngadjui BT, Dongo E, Tamboue E. Prenylated chalcones and flavones from the leaves of Dorstenia kameruniana. Phytochemistry 1998;49:1147-1150.
19. Chen YG, Song XP, Hai LN, LU YP, Fang A, Halaweish F, et al. Compounds with DNA cleaving activity from Kadsura ananosma. Pharmazie 2006;10:891-892.
20. Kuete V, Ngameni B, Tangmouo JG, Bolla JM, Alibert-Franco S, Ngadjui BT, et al. Efflux pumps are involved in the Gram negative bacterial defense against isobavachalcone and diospyrone, two natural products. Antimicrob Agents Chemother 2010;54:1749-1752.
21. Yin S, Fan CQ, Wang Y, Dong L, Yue JM. Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their structure-activity relationship study. Bioorg Med Chem 2004;12:4387-4392.
22. Avila HP, Smânia Ede F, Monache FD, Smânia A Jr. Structureactivity relationship of antibacterial chalcones. Bioorg Med Chem 2008;16:9790-9794.
23. Kuete V, Ngameni B, Mbaveng AT, Ngadjui B, Marion Meyer JJ, Lall N. Evaluation of flavonoids from Dorstenia barteri for their antimycobacterial, antigonorrheal and anti-reverse transcriptase activities. Acta Trop 2010;116:100-104.
24. Nishimura R, Tabata K, Arakawa M, Ito Y, Kimura Y, Akihisa T, et al. Isobavachalcone, a chalcone constituent of Angelica keiskei induces apoptosis in neuroblastoma. Biol Pharm Bull 2007;30:1878-1883.
25. Jing H, Zhou X, Dong X, Cao J, Zhu H, Lou J, et al. Abrogation of Akt signaling by Isobavachalcone contributes to its antiproliferative effects towards human cancer cells. Cancer Lett 2010;294:167-177.
26. Vivanco I, Sawyers CL. Review: the phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
27. Luo J, Manning BD, Cantley LC. Review: targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003;4:257-262.
28. Akihisa T, Tokuda H, Hasegawa D, Ukiya M, Kimura Y, Enjo F, et al. Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J Nat Prod 2006;69:38-42.
29. Akihisa T, Tokuda H, Ukiya M, Iizuka M, Schneidera S, Ogasawara K, et al. Chalcones, coumarins, and flavanones from the exudates of Angelica keiskei and their chemopreventive effects. Cancer Lett 2003;201:133-137.
30. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 1997;110:2473-2482.
31. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci 2003;8:e261-e269.
32. Ngameni B, Touaibia M, Belkaid A, Ambassa P, Watchueng J, Patnama R, et al. Inhibition of matrix metalloproteinase-2 secretion by chalcones from the twigs of Dorstenia barteri Bureau. Arkivoc 2007;ix:91-103.
33. Szliszka E, Czuba ZP, Mazur B, Sedek L, Paradysz A, Krol W. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 2009;11:1-13.
34. Lim SH, Ha TY, Ahn J, Kim S. Estrogenic activities of Psoralea corylifolia L. seed extracts and main constituents. Phytomed 2011;18:425-430.
35. Xiao G, Li G, Chen L, Zhang Z, Yin JJ, Wu T, et al. Isolation of antioxidants from Psoralea corylifolia fruits using highspeed counter-current chromatography guided by thin layer chromatography-antioxidant autographic assay. J Chromatogr A 2010;1217:5470-5476.
36. Haraguchi H, Inoue J, Tamura Y, Mizutani K. Antioxidative components of Psoralea corylifolia (Leguminosae). Phytother Res 2002;16:539-544.
37. Jantan I, Mohd Yasin YH, Jamil S, Sirat H, Basar N. Effect of prenylated flavonoids and chalcones isolated from Artocarpus species on platelet aggregation in human whole blood. J Nat Med 2010;64:365-369.
38. Choi JH, Rho MC, Lee SW, Choi JN, Kim K, Song GY, et al. Bavachin and isobavachalcone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia. Arch Pharm Res 2008; 31:1419-1423.
39. Omisore NO, Adewunmi CO, Iwalewa EO, Ngadjui BT, Adenowo TK, Abegaz BM, et al. Antitrichomonal and antioxidant activities of Dorstenia barteri and Dorstenia convexa. Braz J Med Biol Res 2005;38:1087-1094
40. Matsuda H, Kiyohara S, Sugimoto S, Ando S, Nakamura S, Yoshikawa M. Bioactive constituents from Chinese natural medicines. Inhibitors from the seeds of Psoralea corylifolia on production of nitric oxide in lipopolysaccharide- activated macrophages. Biol Pharm Bull 2009;32:147-149.
41. Winkel-Shirley B. Flavonoid Biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 2001;126:485-493.
42. Sugamoto K, Matsusita Y, Matsui K, Kurogi C, Matsui T. Synthesis and antibacterial activity of chalcones bearing prenyl or geranyl groups from Angelica keiskei. Tetrahedron 2011;67:5346-5359.
43. Zangade S, Mokle S, Vibhute A, Vibhute Y. An efficient and operationally simple synthesis of some new chalcones by using grinding technique. Chem Sci J 2011;13:1-6.
44. Choudhary AN, Juyal V. Synthesis of chalcone and their derivatives as antimicrobial agents. Int J Pharm Pharm Sci 2011;3:125-128.
45. Tsukerman SV, Izvekov VP, Lavrushin VF. Synthesis of chalcone analogs-4- and 5-nitropyrrole derivatives. Chem Hetrocyclic Compounds 1969;5:203-205.
46. Kamal A, Dastagiri D, Ramaiah MJ, Reddy JS, Bharathi EV, Srinivas C, et al. Synthesis of imidazothiazole-chalcone derivatives as anticancer and apoptosis inducing agents. Chem Med Chem 2010;5:1937-1947.
47. Zhang XW, Zhao DH, Quan YC, Sun LP, Yin XM, Guan LP. Synthesis and evaluation of antiinflammatory activity of substituted chalcone derivatives. Med Chem Res 2010;19:403-412.
48. Dong X, Chen J, Jiang C, Liu T, Hu Y. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents. Arch Pharm (Weinheim) 2009;342:428-432.
49. Vitali A, Giardina B, Delle Monache G, Rocca F, Silvestrini A, Tafi A, et al. Chalcone dimethylallyltransferase from Morus nigra cell cultures. Substrate specificity studies. FEBS Lett 2004;557:33-38.